Navigation Links

ProductsVERSANT HIV RNA 3.0 Assay (bDNA)
Company Siemens Medical Solutions Diagnostics
Item VERSANT HIV RNA 3.0 Assay (bDNA)
  • Unmatched precision - Only viral load test precise enough to distinguish three-fold (0.5 log10) changes across the entire assay range, the minimal change considered significant per US DHHS guidelines 1
  • Excellent sensitivity - Determines reliable quantitation of low viral load levels down to 50 copies/mL
  • Exceptional standardization - Traceable to WHO HIV-1 RNA International standards (97/656)
Description The VERSANT HIV-1 RNA Assay (bDNA) delivers unmatched precision and reproducibility, so you can be confident that you're providing physicians with viral load values they can trust. you detect significant changes at the low end and at other critical decision points - without the variability seen with other assays. If you need more reasons to choose VERSANT HIV bDNA, consider this: it's the only viral load assay specifically designed to target multiple sequences on the HIV-1 genome, facilitating detection of all major HIV-1 subtypes. You get reliable, reproducible results that you can depend on, today and tomorrow. Confidence for you and all your patients.
Info Siemens Medical Solutions Diagnostics
Customer Service: 800-255-3232 or 914-631-8000
Web site:

Related medicine products :

1. Uric Acid Enzymatic Assay
2. Lithium Enzymatic Assay Kit
3. Retinol Binding Protein EIA Vitamin Assays 030-6110 RBP Bone and Minearl Metabolism
4. Vitamin B6 Jumbo REA Vitamin Assays, Cardiovascular 001-RK-VB6N
5. Vitamin B6 REA Vitamin Assays, Cardiovascular 001-RK-VB6
6. Procleix HIV-1/HCV Assay
7. Wampole PreVue B. Burgdorferi Antibody Detection Assay
8. VerifyNow Aspirin Assay
9. VerifyNow IIb/IIIa Assay
10. VerifyNow Clopidogrel Assay
11. VITROS® Anti-HBs Assay
Quatroloc Revision Hip System...
A stable revision design with extensive sizes...
Severe revision options for the knee and hip...
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem....
Medicine Products:
(Date:10/13/2017)... OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... or dementia. However, many long-term care insurance companies have a waiver for care if ... the 90-day elimination period, when the family pays for care, is often waived, so ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Global Healthcare ... scenic Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare ... activity. The fun run is geared towards children of all ages; it is ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... advisory services for healthcare compliance program management, will showcase a range of technology ... Association for Assisted Living (NCAL) Convention and Expo to be held October 14–18, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host its fiscal ... Friday, November 3, 2017, beginning at 7:00 a.m. (CDT) ... a.m. (CDT) / 9:30 a.m. (EDT). In ... guidance for 2018, Hill-Rom executives will also highlight the ... long-range financial outlook through 2020. ...
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global ... that its MyDario product is expected to appear on The Dr. Oz ... Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, The Dr. Oz Show kicked ... The segment features ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology: